| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-27 23:22:21 UTC |
|---|
| Updated at | 2022-04-27 23:22:21 UTC |
|---|
| NP-MRD ID | NP0052242 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Oroxylin A |
|---|
| Description | 5,7-Dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one, also known as 5,7-dihydroxy-6-methoxyflavone or baicalein 6-methyl ether, belongs to the class of organic compounds known as 6-o-methylated flavonoids. These are flavonoids with methoxy groups attached to the C6 atom of the flavonoid backbone. Thus, 5,7-dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one is considered to be a flavonoid lipid molecule. Oroxylin A is found in Adenostoma sparsifolium, Agrobacterium rhizogenes, Bupleurum scorzonerifolium , Capparis himalayensis, Carthamus glauca, Centaurea pseudoscabiosa, Eucommia ulmoides, Flourensia laurifolia, Gomphrena boliviana, Gomphrena martiana, Lagochilus leiacanthus, Muntingia calabura, Oroxylum indicum , Pajanelia multijuga, Phonus arborescens, Rhinacanthus nasutus, Scutellaria alpina, Scutellaria altissima, Scutellaria amoena, Scutellaria baicalensis, Scutellaria baicalensis GEORGI , Scutellaria galericulata, Scutellaria hypericifolia, Scutellaria lateriflora, Scutellaria likiangensis, Scutellaria racemosa, Scutellaria rehderiana, Scutellaria seleriana, Scutellaria squarrosa, Scutellaria strigillosa and Scutellaria viscidula. Oroxylin A was first documented in 2003 (PMID: 12818372). 5,7-Dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral (PMID: 22366656) (PMID: 22560876) (PMID: 23238475) (PMID: 23371806). |
|---|
| Structure | COC1=C(O)C2=C(OC(=CC2=O)C2=CC=CC=C2)C=C1O InChI=1S/C16H12O5/c1-20-16-11(18)8-13-14(15(16)19)10(17)7-12(21-13)9-5-3-2-4-6-9/h2-8,18-19H,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 5,7-Dihydroxy-6-methoxy-2-phenyl-4H-1-benzopyran-4-one | ChEBI | | 5,7-Dihydroxy-6-methoxyflavone | ChEBI | | Baicalein 6-methyl ether | ChEBI | | Oroxylin | MeSH | | 5,7-Dihydroxy-6-methoxy-2-phenylchromen-4-one | MeSH |
|
|---|
| Chemical Formula | C16H12O5 |
|---|
| Average Mass | 284.2670 Da |
|---|
| Monoisotopic Mass | 284.06847 Da |
|---|
| IUPAC Name | 5,7-dihydroxy-6-methoxy-2-phenyl-4H-chromen-4-one |
|---|
| Traditional Name | oroxylin A |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=C(O)C2=C(OC(=CC2=O)C2=CC=CC=C2)C=C1O |
|---|
| InChI Identifier | InChI=1S/C16H12O5/c1-20-16-11(18)8-13-14(15(16)19)10(17)7-12(21-13)9-5-3-2-4-6-9/h2-8,18-19H,1H3 |
|---|
| InChI Key | LKOJGSWUMISDOF-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 6-o-methylated flavonoids. These are flavonoids with methoxy groups attached to the C6 atom of the flavonoid backbone. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Flavonoids |
|---|
| Sub Class | O-methylated flavonoids |
|---|
| Direct Parent | 6-O-methylated flavonoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - 6-methoxyflavonoid-skeleton
- 5-hydroxyflavonoid
- 7-hydroxyflavonoid
- Flavone
- Hydroxyflavonoid
- Chromone
- Benzopyran
- 1-benzopyran
- Anisole
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Pyranone
- Monocyclic benzene moiety
- Benzenoid
- Pyran
- Vinylogous acid
- Heteroaromatic compound
- Ether
- Organoheterocyclic compound
- Oxacycle
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Huen MS, Leung JW, Ng W, Lui WS, Chan MN, Wong JT, Xue H: 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem Pharmacol. 2003 Jul 1;66(1):125-32. doi: 10.1016/s0006-2952(03)00233-8. [PubMed:12818372 ]
- Pham TA, Che H, Phan PT, Lee JW, Kim SS, Park H: Oroxylin A analogs exhibited strong inhibitory activities against iNOS-mediated nitric oxide (NO) production. Bioorg Med Chem Lett. 2012 Apr 1;22(7):2534-5. doi: 10.1016/j.bmcl.2012.01.135. Epub 2012 Feb 8. [PubMed:22366656 ]
- Zou M, Lu N, Hu C, Liu W, Sun Y, Wang X, You Q, Gu C, Xi T, Guo Q: Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal. 2012 Aug;24(8):1722-32. doi: 10.1016/j.cellsig.2012.04.009. Epub 2012 Apr 25. [PubMed:22560876 ]
- Song X, Chen Y, Sun Y, Lin B, Qin Y, Hui H, Li Z, You Q, Lu N, Guo Q: Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide. Pharmacol Rep. 2012;64(5):1189-99. doi: 10.1016/s1734-1140(12)70915-5. [PubMed:23238475 ]
- Yoon SY, dela Pena I, Kim SM, Woo TS, Shin CY, Son KH, Park H, Lee YS, Ryu JH, Jin M, Kim KM, Cheong JH: Oroxylin A improves attention deficit hyperactivity disorder-like behaviors in the spontaneously hypertensive rat and inhibits reuptake of dopamine in vitro. Arch Pharm Res. 2013 Jan;36(1):134-40. doi: 10.1007/s12272-013-0009-6. [PubMed:23371806 ]
|
|---|